1. Home
  2. RLMD vs HKIT Comparison

RLMD vs HKIT Comparison

Compare RLMD & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • HKIT
  • Stock Information
  • Founded
  • RLMD 2004
  • HKIT 1996
  • Country
  • RLMD United States
  • HKIT China
  • Employees
  • RLMD N/A
  • HKIT N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • HKIT Computer Software: Prepackaged Software
  • Sector
  • RLMD Health Care
  • HKIT Technology
  • Exchange
  • RLMD Nasdaq
  • HKIT Nasdaq
  • Market Cap
  • RLMD 67.7M
  • HKIT 54.8M
  • IPO Year
  • RLMD N/A
  • HKIT 2023
  • Fundamental
  • Price
  • RLMD $2.09
  • HKIT $2.28
  • Analyst Decision
  • RLMD Hold
  • HKIT
  • Analyst Count
  • RLMD 2
  • HKIT 0
  • Target Price
  • RLMD $1.00
  • HKIT N/A
  • AVG Volume (30 Days)
  • RLMD 335.3K
  • HKIT 24.5K
  • Earning Date
  • RLMD 11-07-2025
  • HKIT 04-08-2026
  • Dividend Yield
  • RLMD N/A
  • HKIT N/A
  • EPS Growth
  • RLMD N/A
  • HKIT N/A
  • EPS
  • RLMD N/A
  • HKIT N/A
  • Revenue
  • RLMD N/A
  • HKIT $1,812,901.00
  • Revenue This Year
  • RLMD N/A
  • HKIT N/A
  • Revenue Next Year
  • RLMD N/A
  • HKIT N/A
  • P/E Ratio
  • RLMD N/A
  • HKIT N/A
  • Revenue Growth
  • RLMD N/A
  • HKIT N/A
  • 52 Week Low
  • RLMD $0.24
  • HKIT $1.15
  • 52 Week High
  • RLMD $3.98
  • HKIT $2.34
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 55.74
  • HKIT 80.05
  • Support Level
  • RLMD $1.98
  • HKIT $1.80
  • Resistance Level
  • RLMD $2.27
  • HKIT $1.92
  • Average True Range (ATR)
  • RLMD 0.21
  • HKIT 0.13
  • MACD
  • RLMD -0.04
  • HKIT 0.02
  • Stochastic Oscillator
  • RLMD 64.22
  • HKIT 83.33

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About HKIT Hitek Global Inc.

Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.

Share on Social Networks: